Prevalence of carbapenemase-producing Enterobacteriaceae and its impact on clinical outcomes at a teaching hospital in Taiwan

Journal of the Formosan Medical Association

Volumn 112, Issue 8, 2013, Pages 492-496

  Lai, Chung Chih ^a,b   Wu, Un In ^b   Wang, Jann Tay ^b   Chang, Shan Chwen ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Carbapenemase; Ertapenem nonsusceptible Enterobacteriaceae; Minimal inhibitory concentration; Treatment outcomes

Indexed keywords

AMIKACIN; CARBAPENEM; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEPHALOSPORIN; COLISTIN; FLOMOXEF; IMIPENEM; MEROPENEM; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE;

ABDOMINAL INFECTION; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; FEMALE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PREVALENCE; SKIN INFECTION; SOFT TISSUE INFECTION; TAIWAN; TEACHING HOSPITAL; TREATMENT OUTCOME; URINARY TRACT INFECTION;

CARBAPENEMASE; ERTAPENEM-NONSUSCEPTIBLE ENTEROBACTERIACEAE; MINIMAL INHIBITORY CONCENTRATION; TREATMENT OUTCOMES;

AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; BETA-LACTAMASES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HOSPITALS, TEACHING; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; TAIWAN; TREATMENT OUTCOME;

EID: 84883559678     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/j.jfma.2012.09.021     Document Type: Article

References (18)

1. Neuner E.A., Yeh J.-Y., Hall G.S., Sekeres J., Endimiani A., Bonomo R.A., et al. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagnostic Microbiology and Infectious Disease 2011, 69:357-362.
2. Queenan A.M., Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 2007, 20:440-458.
3. Performance standards for antimicrobial susceptibility testing. 19th informational supplement. CLSI document M100-S19 2007, Clinical and Laboratory Standards Institute, Clinical and Laboratory Standard Institute, Wayne, PA.
4. Performance standards for antimicrobial susceptibility testing. 20th informational supplement (June 2010, update). CLSI document M100-S20-U 2010, Clinical and Laboratory Standard Institute, Clinical and Laboratory Standard Institute, Wayne, PA.
5. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI document M100-S20 2010, Clinical and Laboratory Standard Institute, Clinical and Laboratory Standard Institute, Wayne, PA.
6. Liao C.H., Sheng W.H., Wang J.T., Sun H.Y., Wang H.K., Hsueh P.R., et al. Invitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan. J Microbiol Immunol Infect 2006, 39:59-66.
7. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters.Version 1.3, ; [accessed 21.02.12]. http://www.eucast.org/eucast_susceptibility_testing/breakpoints/.
8. Pillar C.M., Draghi D.C., Dowzicky M.J., Sahm D.F. Invitro activity of tigecycline against gram-positive and gram-negative pathogens as evaluated by broth microdilution and Etest. J Clin Microbiol 2008, 46:2862-2867.
9. Mochon A.B., Garner O.B., Hindler J.A., Krogstad P., Ward K.W., Lewinski M.A., et al. New Delhi metallo-beta-lactamase (NDM-1)-producing Klebsiella pneumoniae: case report and laboratory detection strategies. J Clin Microbiol 2011, 49:1667-1670.
10. Tsai H.T., Wang J.T., Chen C.J., Chang S.C. Association between antibiotic usage and subsequent colonization or infection of extensive drug-resistant Acinetobacter baumannii: a matched case-control study in intensive care units. Diagn Microbiol Infect Dis 2008, 62:298-305.
11. Tseng Y.C., Wang J.T., Wu F.L., Chen Y.C., Chie W.C., Chang S.C. Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis 2007, 59:181-190.
12. Chung K.P., Tseng S.P., Huang Y.T., Tsai T.H., Teng L.J., Hsueh P.R. Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan. J Antimicrob Chemother 2011, 66:1182-1184.
13. Lai C.C., Lin T.L., Tseng S.P., Huang Y.T., Wang J.T., Chang S.C., et al. Pelvic abscess caused by New Delhi metallo-β-lactamase-1-producing Klebsiella oxytoca in Taiwan in a patient who underwent renal transplantation in China. Diagn Microbiol Infect Dis 2011, 71:474-475.
14. Yan J.J., Wu J.J., Lee C.C., Ko W.C., Yang F.C. Prevalence and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007. Eur J Clin Microbiol Infect Dis 2010, 29:1417-1425.
15. Gupta N., Limbago B.M., Patel J.B., Kallen A.J. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011, 53:60-67.
16. Pasteran F., Mendez T., Rapoport M., Guerriero L., Corso A. Controlling false-positive results obtained with the Hodge and Masuda assays for detection of class A carbapenemase in species of Enterobacteriaceae by incorporating boronic acid. JClin Microbiol 2010, 48:1323-1332.
17. Daikos G.L., Markogiannakis A. Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?. Clin Microbiol Infect 2011, 17:1135-1141.
18. Lee C.M., Liao C.H., Lee W.S., Liu Y.C., Mu J.J., Lee M.C., et al. Outbreak of Klebsiella pneumoniae carbapenemase-2- producing K. pneumoniae sequence type 11 in Taiwan, 2011. Antimicrob Agents Chemother 2012, 56:5016-5022.